STACY HORN: Open Payments
NPI 1962851121 · TERRE HAUTE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$530 in 26 payments from 12 companies in 2025. Trend: 2023 $1,367 · 2024 $996 · 2025 $530
Food & beverage: $530
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $168 |
| Novo Nordisk Inc | 4 | $78 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $58 |
| Amgen Inc. | 3 | $48 |
| Axsome Therapeutics, Inc. | 1 | $33 |
| Boston Scientific Corporation | 1 | $30 |
| Corium, LLC | 2 | $27 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Lundbeck LLC | 1 | $19 |
| Lilly USA, LLC | 1 | $18 |
Products named: UBRELVY, Kerendia, Wegovy, REXULTI, OTEZLA, Auvelity, WATCHMAN FLX, QULIPTA.
Industry payments across IN — which companies pay providers there.
